| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,374 |
10,202 |
$496K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,346 |
3,340 |
$326K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,044 |
2,031 |
$146K |
| 20610 |
|
4,784 |
2,174 |
$85K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,063 |
948 |
$27K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
537 |
211 |
$16K |
| 99442 |
|
100 |
98 |
$6K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
684 |
665 |
$3K |
| 99443 |
|
24 |
24 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
38 |
38 |
$2K |
| 96401 |
|
24 |
24 |
$967.26 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
207 |
194 |
$521.64 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
148 |
134 |
$237.38 |
| 3074F |
|
321 |
305 |
$36.00 |
| 3078F |
|
330 |
307 |
$36.00 |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
433 |
140 |
$17.43 |
| 3079F |
|
59 |
57 |
$9.00 |
| 3075F |
|
13 |
12 |
$0.00 |
| 3077F |
|
27 |
24 |
$0.00 |